These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32014008)

  • 21. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
    Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
    Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling.
    Wang J; Jia Q; Sun J; Wu S; Wei L; Yao W
    Cancer Biol Ther; 2024 Dec; 25(1):2408042. PubMed ID: 39341782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.
    Zhang BX; Yu T; Yu Z; Yang XG
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6497-6504. PubMed ID: 31378889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
    Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J
    Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
    Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
    Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
    Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
    Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
    Li FZ; Zang WQ
    World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma.
    Li Y; Jiang X; Yan X; Wang Y
    Thorac Cancer; 2021 Mar; 12(6):752-759. PubMed ID: 33481352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WTAP/CCND1 axis accelerates esophageal squamous cell carcinoma progression by MAPK signaling pathway.
    Zhang H; Zhang X; Zhang Y; Wu J; Li J; Shan B
    Neoplasma; 2024 Aug; 71(4):359-373. PubMed ID: 39267543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
    Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
    Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.